Restorative Effects of Camellia Oil on the Skin-barrier Function in a Model of DNCB-induced Atopic Dermatitis

Overview

Journal Eur J Histochem

Date 2025 Jan 21

PMID 39836107

Authors

Shicheng Jiao

Lijun Deng

Mu Niu

Jie Yang

Affiliations

Soon will be listed here.

Abstract

This study aimed to evaluate the therapeutic efficacy of camellia oil on 2,4-dinitrochlorobenzene (DNCB)-induced atopic dermatitis (AD) in mice, as well as its effect on the expression of skin-barrier-related proteins. A mouse model of AD was created via topical application of DNCB; subsequently, the animals were randomly divided into four groups: the blank control (Control), model (Model), moisturizing cream (Moisturizer), and camellia oil (Camellia) groups. The Camellia group received camellia oil, whereas the Moisturizer group was treated with moisturizing cream, as a positive control. Skin lesions, ear and back tissue morphology, and the serum levels of IgE, IL-4, and IFN-γ were analyzed. Compared with the Control group, AD mice exhibited erythema, papules, dryness, peeling, and significantly higher serum IgE and IL-4 levels. Compared with the Model group, treatment with camellia oil and moisturizing cream considerably reduced skin inflammation, ear thickness, and scratching frequency. A histopathological analysis revealed that camellia oil reduced inflammatory-cell infiltration and edema in the AD-affected skin. Furthermore, camellia oil upregulated filaggrin (FLG), thus aiding in skin-barrier repair. These findings suggest that camellia oil significantly improves AD symptoms, enhances FLG expression, and restores the damaged skin barrier in AD mouse models.

References

Johnson E, Irons J, Patterson R, Roberts M . Serum IgE concentration in atopic dermatitis. Relationship to severity of disease and presence of atopic respiratory disease. J Allergy Clin Immunol. 1974; 54(2):94-9. DOI: 10.1016/0091-6749(74)90037-2. View

Cole C, Kroboth K, Schurch N, Sandilands A, Sherstnev A, ORegan G . Filaggrin-stratified transcriptomic analysis of pediatric skin identifies mechanistic pathways in patients with atopic dermatitis. J Allergy Clin Immunol. 2014; 134(1):82-91. PMC: 4090750. DOI: 10.1016/j.jaci.2014.04.021. View

Wollenberg A, Werfel T, Ring J, Ott H, Gieler U, Weidinger S . Atopic Dermatitis in Children and Adults—Diagnosis and Treatment. Dtsch Arztebl Int. 2023; 120(13):224-234. PMC: 10277810. DOI: 10.3238/arztebl.m2023.0011. View

Sroka-Tomaszewska J, Trzeciak M . Molecular Mechanisms of Atopic Dermatitis Pathogenesis. Int J Mol Sci. 2021; 22(8). PMC: 8074061. DOI: 10.3390/ijms22084130. View

Huang S, Yang X, Mo L, Zhou X . [Optimization of emollient formulation for treating atopic dermatitis by skin physiological index testing]. Nan Fang Yi Ke Da Xue Xue Bao. 2017; 37(7):967-974. PMC: 6765524. View

Eyerich S, Eyerich K, Traidl-Hoffmann C, Biedermann T . Cutaneous Barriers and Skin Immunity: Differentiating A Connected Network. Trends Immunol. 2018; 39(4):315-327. DOI: 10.1016/j.it.2018.02.004. View

Jung E, Lee J, Baek J, Jung K, Lee J, Huh S . Effect of Camellia japonica oil on human type I procollagen production and skin barrier function. J Ethnopharmacol. 2007; 112(1):127-31. DOI: 10.1016/j.jep.2007.02.012. View

Debinska A . New Treatments for Atopic Dermatitis Targeting Skin Barrier Repair via the Regulation of FLG Expression. J Clin Med. 2021; 10(11). PMC: 8200961. DOI: 10.3390/jcm10112506. View

Pesce G, Marcon A, Carosso A, Antonicelli L, Cazzoletti L, Ferrari M . Adult eczema in Italy: prevalence and associations with environmental factors. J Eur Acad Dermatol Venereol. 2014; 29(6):1180-7. DOI: 10.1111/jdv.12784. View

10.

Kim S, Jung E, Shin S, Kim M, Kim Y, Lee J . Anti-inflammatory activity of Camellia japonica oil. BMB Rep. 2012; 45(3):177-82. DOI: 10.5483/BMBRep.2012.45.3.177. View

11.

Guttman-Yassky E, Nograles K, Krueger J . Contrasting pathogenesis of atopic dermatitis and psoriasis--part I: clinical and pathologic concepts. J Allergy Clin Immunol. 2011; 127(5):1110-8. DOI: 10.1016/j.jaci.2011.01.053. View

12.

Yang G, Qi Z, Shan S, Xie D, Tan X . Advances in Separation, Biological Properties, and Structure-Activity Relationship of Triterpenoids Derived from Abel. J Agric Food Chem. 2024; 72(9):4574-4586. DOI: 10.1021/acs.jafc.3c09168. View

13.

Armengot-Carbo M, Hernandez-Martin A, Torrelo A . The role of filaggrin in the skin barrier and disease development. Actas Dermosifiliogr. 2014; 106(2):86-95. DOI: 10.1016/j.ad.2013.10.019. View

14.

Wang Y, Zhang P, Zhang J, Hong T . Inhibitory Effect of Bisdemethoxycurcumin on DNCB-Induced Atopic Dermatitis in Mice. Molecules. 2023; 28(1). PMC: 9822078. DOI: 10.3390/molecules28010293. View

15.

Lopez Carrera Y, Hammadi A, Huang Y, Llamado L, Mahgoub E, Tallman A . Epidemiology, Diagnosis, and Treatment of Atopic Dermatitis in the Developing Countries of Asia, Africa, Latin America, and the Middle East: A Review. Dermatol Ther (Heidelb). 2019; 9(4):685-705. PMC: 6828917. DOI: 10.1007/s13555-019-00332-3. View

16.

Zhang T, Qiu F, Chen L, Liu R, Chang M, Wang X . Identification and in vitro anti-inflammatory activity of different forms of phenolic compounds in Camellia oleifera oil. Food Chem. 2020; 344:128660. DOI: 10.1016/j.foodchem.2020.128660. View

17.

Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J . Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018; 9(6):7204-7218. PMC: 5805548. DOI: 10.18632/oncotarget.23208. View

18.

Kim D, Kobayashi T, Nagao K . Research Techniques Made Simple: Mouse Models of Atopic Dermatitis. J Invest Dermatol. 2019; 139(5):984-990.e1. PMC: 6555635. DOI: 10.1016/j.jid.2019.02.014. View

19.

Lee H, Patel K, Singam V, Rastogi S, Silverberg J . A systematic review and meta-analysis of the prevalence and phenotype of adult-onset atopic dermatitis. J Am Acad Dermatol. 2018; 80(6):1526-1532.e7. DOI: 10.1016/j.jaad.2018.05.1241. View

20.

Simpson E, Bieber T, Eckert L, Wu R, Ardeleanu M, Graham N . Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults. J Am Acad Dermatol. 2016; 74(3):491-8. DOI: 10.1016/j.jaad.2015.10.043. View